Given that a subset of RA patients are genetic carriers of human leukocyte antigen (HLA)-DR alleles which encodes the MHC complex, it is plausible to hypothesize that a mutation in the MHC class II cells, together with microbiome dysbiosis, may set the stage for the development of RA [1]. This evidence concerns the gene HLA-C and rheumatoid arthritis.